Press Release

메가존클라우드, 팜캐드와 효율적 신약 개발 위한 양자컴퓨팅 협력 MegazoneCloud and PharmCADD Sign MOU on Quantum Computing for New Drug Development.

메가존클라우드, 팜캐드와 효율적 신약 개발 위한 양자컴퓨팅 협력 MegazoneCloud and PharmCADD Sign MOU on Quantum Computing for New Drug Development. 더 읽기"

정부, 내년 양자 신규사업 7건에 491억원 풀어 | 한국양자산업리더스포럼서 첫 공개…계속사업 17건 포함 총 2004억원 투입

정부, 내년 양자 신규사업 7건에 491억원 풀어 | 한국양자산업리더스포럼서 첫 공개…계속사업 17건 포함 총 2004억원 투입 더 읽기"

한·일 경제단체 “한국 스타트업 일본 진출 공동 지원”

한·일 경제단체 “한국 스타트업 일본 진출 공동 지원” 더 읽기"

뿌리 내리는 양자컴퓨팅 기술…AI로 신약 개발 나선다

뿌리 내리는 양자컴퓨팅 기술…AI로 신약 개발 나선다 더 읽기"

PharmCADD and partners participated in the “Quantum Korea 2023”

PharmCADD and partners participated in the “Quantum Korea 2023” 더 읽기"

PharmCADD and partners were selected for the 2023 Quantum Computing-Based Challenging Project.

PharmCADD and partners were selected for the 2023 Quantum Computing-Based Challenging Project. 더 읽기"

ISU ABXIS-PharmCADD jointly announces “research will provide novel insights to design effective anti-cancer therapeutics for targeting MEK1/2 for neurofibromatosis” in EACR

ISU ABXIS-PharmCADD jointly announces “research will provide novel insights to design effective anti-cancer therapeutics for targeting MEK1/2 for neurofibromatosis” in EACR 더 읽기"

PharmCADDㆍPNU signed an MOU for Anticancer Drug Development

PharmCADDㆍPNU signed an MOU for Anticancer Drug Development 더 읽기"

PharmCADD announced the ‘Biotech Showase 2023’ and ‘RESI conference’ held in San Francisco, USA

PharmCADD announced the ‘Biotech Showase 2023’ and ‘RESI conference’ held in San Francisco, USA 더 읽기"

Korean startups using AI in drug discovery; Especially clinical trial success using AI at PharmCADD.

Korean startups using AI in drug discovery; Especially clinical trial success using AI at PharmCADD. 더 읽기"